JACQUELINE HANSON: Open Payments
NPI 1790221034 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 63 payments from 19 companies in 2025. Trend: 2023 $942 · 2024 $1,534 · 2025 $1,366
Food & beverage: $1,366
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $179 |
| United Therapeutics Corporation | 6 | $170 |
| GlaxoSmithKline, LLC. | 12 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $132 |
| Paratek Pharmaceuticals, Inc. | 5 | $130 |
| GENZYME CORPORATION | 4 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $76 |
| JAZZ PHARMACEUTICALS INC. | 3 | $73 |
| Tactile Systems Technology Inc | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
Products named: Tyvaso, DUPIXENT, NUZYRA, TRELEGY ELLIPTA, OFEV, FASENRA, GLASSIA, RYLAZE.
Industry payments across TX — which companies pay providers there.
